Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Hagenbuchner
O-090 Foxo3 Is Activated in High-Risk Neuroblastoma and Contributes to Chemotherapy-Resistance and Angiogenesis
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Related publications
Select BCL-2 Antagonism Restores Chemotherapy Sensitivity in High-Risk Neuroblastoma
BMC Cancer
Cancer Research
Oncology
Genetics
Impact of MYCN Status on Response of High-Risk Neuroblastoma to Neoadjuvant Chemotherapy
Journal of Pediatric Surgery
Medicine
Child Health
Surgery
Pediatrics
Perinatology
Telomere Maintenance Is Pivotal for High-Risk Neuroblastoma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
Amplification of LAPTM4B and YWHAZ Contributes to Chemotherapy Resistance and Recurrence of Breast Cancer
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue
Bone Marrow Transplantation
Transplantation
Hematology
Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma
Clinical Cancer Research
Cancer Research
Oncology
Exosomal WNT-Induced Dedifferentiation of Colorectal Cancer Cells Contributes to Chemotherapy Resistance
Oncogene
Cancer Research
Genetics
Molecular Biology
Efficacy and Risk Factors Associated to Resistance to Single-Agent Chemotherapy in Low-Risk Gestational Trophoblastic Neoplasia
Open Journal of Obstetrics and Gynecology
